Peptide Therapeutics Market by Application (Metabolic, Cardiovascular Disorder, Respiratory, GIT, Anti-infection, Pain, Dermatology, CNS, Renal, and Others), Drug Type (Generic and Innovative), Type of Manufacturing (In-house and Outsourced), Synthesis Technology (Liquid Phase Peptide Synthesis (LPPS), Solid Phase Peptide Synthesis (SPPS), and Hybrid Technology) and Geography – Global Forecast up to 2026

  • May, 2021
  • Domain: Healthcare - Pharmaceuticals
Pages: 109
Tables: 88
Charts: 118
Regions/Countries: 4 / 10
Companies: 10
Enquiry Hours: 10
  • Get Free 10% Customization in this Report

Peptides are naturally happening biological molecules which play an essential role in significant biological activities. Many efforts have been taken in pharmaceutical research and development to evolve new peptides for the treatment of various chronic diseases. Around 7000 naturally active peptides have been discovered in the past few years, which act as hormones, neurotransmitters, ion channel ligands, and growth factors to provide various human physiologies. The growth of the Peptide Therapeutics market is directly related to increasing investments in drug discovery. R&D activities in peptide therapeutics are majorly focused on the evolution of drugs related to oncology and metabolic disorders, infectious diseases, and diabetes. A robust product pipeline in this field is also one of the factors projected to propel market growth soon. Besides the market growth drivers, the market restricting factors are the huge cost incurred in developing drugs and restricted regulatory requirements for drug approval. The Peptide Therapeutics Market is estimated to grow at the rate of 9.67% CAGR by 2026.  

Research Methodology:

The Peptide Therapeutics Market has been analyzed by utilizing the optimum combination of secondary sources and in-house methodology and a unique balance of primary insights. The real-time valuation of the market is an integral part of our forecasting and market sizing methodology. Industry experts and our primary participants have helped to compile related aspects with accurate parametric estimations for a complete study. The primary participants share is given below:

Peptide Therapeutics Market

Peptide Therapeutics Market by Application

  • Metabolic
  • Cardiovascular Disorder
  • Respiratory
  • GIT
  • Anti-infection
  • Pain
  • Dermatology
  • CNS
  • Renal
  • Others

Peptide Therapeutics Market by Drug Type

  • Generic
  • Innovative

Peptide Therapeutics Market by Type of Manufacturing

  • In-house
  • Outsourced

Peptide Therapeutics Market by Synthesis Technology

  • Solid Phase Peptide Synthesis (SPPS)
  • Liquid Phase Peptide Synthesis (LPPS)
  • Hybrid Technology

Peptide Therapeutics Market by Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

The cancer segment has held the maximum share in the peptide therapeutics market on the basis of application. Since there is an increasing number of cancer patients, it is eventually increasing the prescription of peptide therapeutics to treat cancer. Moreover, the rising demand for efficient and faster-acting therapeutics further accentuates the growth of the segment.

As per the market by drug type, the innovative peptides segment has a significant share in the peptide therapeutics market. This is due to the high investments by various pharmaceuticals in research and development activities to develop and discover new drugs for the increasing number of chronic diseases worldwide.

Further, the market is based on the type of manufacturing; in this segmentation, the in-house manufacturing segment has a major contribution to the peptide therapeutics market share. Most players are involved in the in-house manufacturing process due to strict regulations and high costs incurred in outsourcing.

According to the synthesis technology, the liquid phase peptide synthesis (LPPS) segment has dominated the peptide therapeutics market share. The dominance is attributed to the swelling demand for pure peptides in the development of effective therapeutics. Moreover, the liquid phase peptide synthesis holds usefulness in the extensive production of peptides for industrial purposes.

In terms of geographical segmentation, North America has a substantial share of the peptide therapeutics market growth. This is due to the growing demand for diagnostics in cancer, cardiovascular and other diseases, and the expanding biotechnology industry contributes to the dominance.

Cancer coupled with cardiovascular diseases is the major cause of death in the developed countries around the world. Traditional cancer treatments lack therapeutic uses because of drug resistance, a dearth of tumor selectivity and solubility, and a requirement to develop new therapeutic agents. Therapeutic peptides are a potential and a new effort to treat various diseases and cancer, which has increased the demand for peptide therapeutics.

The vital players of the peptide therapeutics market are Teva Pharmaceuticals Industries Ltd., Novo Nordisk A/S, Eli Lilly and Company, Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc (GSK), Novartis International AG, Amgen Inc., Pfizer Inc., Merck & Co. Inc., and Lonza Inc.

Hence, peptide therapeutics is having various prominent advantages when compared to proteins and antibodies. Peptide therapeutics is crucially used in cancer treatment due to the adverse effects of radiation and chemotherapy.

  • This research provides prominent shifts in market dynamics and segmentation details of the peptide therapeutics market.
  • Historical, present, and future market analysis is depicted in this report as qualitative and quantitative.
  • This research also provides the assessment of market developments and emerging segments, and regional markets of the peptide therapeutics market.
  • Essential strategies, company expansions, mergers, acquisitions, and new product launches of major vendors are included in this research.
  1. Executive Summary
  2. Industry Outlook
    1. Industry Overview
    2. Industry Trends
  3. Market Snapshot
    1. Market Definition
    2. Market Outlook
      1. Porter Five Forces
    3. Related Markets
  4. Market characteristics
    1. Market Overview
    2. Market Segmentation
    3. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunities
    4. DRO - Impact Analysis
  5. Application: Market Size & Analysis
    1. Overview
    2. Metabolic
    3. Cardiovascular Disorder
    4. Respiratory
    5. GIT
    6. Anti-infection
    7. Pain
    8. Dermatology
    9. CNS
    10. Renal
    11. Others
  6. Drug Type: Market Size & Analysis
    1. Overview
    2. Generic
    3. Innovative
  7. Type of Manufacturing: Market Size & Analysis
    1. Overview
    2. In-house
    3. Outsourced
  8. Synthesis Technology: Market Size & Analysis
    1. Overview
    2. Solid Phase Peptide Synthesis (SPPS)
    3. Liquid Phase Peptide Synthesis (LPPS)
    4. Hybrid Technology
  9. Geography: Market Size & Analysis
    1. Overview
    2. North America
    3. Europe
    4. Asia Pacific
    5. Rest of the World
  10. Competitive Landscape
    1. Competitor Comparison Analysis
    2. Market Developments
      1. Mergers and Acquisitions, Legal, Awards, Partnerships
      2. Product Launches and execution
  11. Vendor Profiles
    1. Teva Pharmaceuticals Industries Ltd.
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    2. Novo Nordisk A/S
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    3. Eli Lilly and Company
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    4. Takeda Pharmaceutical Company Limited
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    5. GlaxoSmithKline plc (GSK)
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    6. Novartis International AG
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    7. Pfizer Inc
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    8. Merck & Co. Inc
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    9. Lonza Inc
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
  12. Analyst Opinion
  13. Annexure
    1. Report Scope
    2. Market Definitions
    3. Research Methodology
      1. Data Collation and In-house Estimation
      2. Market Triangulation
      3. Forecasting
    4. Report Assumptions
    5. Declarations
    6. Stakeholders
    7. Abbreviations

Research Framework

Infoholic research works on a holistic 360° approach in order to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involves following steps:

  • Data Collation (Primary & Secondary)
  • In-house Estimation (Based on proprietary data bases and Models)
  • Market Triangulation
  • Forecasting

Market related information is congregated from both primary and secondary sources.

Primary sources

involved participants from all global stakeholders such as Solution providers, service providers, Industry associations, thought leaders etc. across levels such as CXOs, VPs and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.

Secondary sources

include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications along with paid sources such as Factiva, OneSource, Bloomberg among others.

Interested in this report?
Get your FREE sample now!

Select User License

$

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer 10% worth of FREE customization at the time of purchase